About MSH/03

Chronic Pain Management

Our Upcoming Chronic Pain Product

Mindset Health is preparing to launch its third product, an app-based hypnotherapy program for sufferers of chronic pain.

Chronic pain is a term used to describe a multidimensional physical experience. The chronic pain umbrella includes: pain intensity, pain persistence, pain-related disability, and recency on onset. The standard definition, developed by the International Association of the Study of Pain, says that chronic pain is the persistence of pain beyond the typical healing phase of an injury or sickness. Because of the wide variety of conditions that can lead to chronic pain, it is difficult to categorize a cause. However, generally chronic pain is due to peripheral nerve injuries that lead to neuropathic pain behavior.

Why Chronic Pain?

  • It affects a huge number of people and is very costly
  • According to the American Academy of Pain Medicine, more than 1.5 billion people around the world have chronic pain. It's the most common cause of long-term disability in the United States, affecting about 100 million people.
  • Between the cost of treatment and lost productivity, chronic pain costs the US economy alone around US$635 billion per year
  • It has significant impacts on and interactions with mental health
  • Research indicates there are strong links between anxiety, depression and chronic physical illness
  • Almost one in three adults with severe or very severe pain have high or very high levels of psychological distress
  • 44.6% of sufferers also live with depression
  • Multidisciplinary pain management has been shown to drive clinically meaningful reductions in depression (57% of users) and anxiety (41%)
  • There remain significant issues around access to multidisciplinary support for chronic pain
  • There is a significant evidence base around the use of psychological therapies and hypnotherapy for chronic pain sufferers - for example, in Australia, usage of multidisciplinary pain management (as opposed to just pharmaceutical management via opioids) allowed almost half of all patients to reduce their opioid usage by 50% or more

Interested in updates?

powered by Typeform

Interested in research opportunities or collaborations?

Reach out to our practitioner team by emailing team@mindsethealth.com.
powered by Typeform